MedTrace Logo

A Zhineng Qigong Intervention for Patients With Chronic Low Back Pain and/or Leg Pain

NCT04520334 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2020-08-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate a Zhineng Qigong intervention for patients with chronic low back pain and/or leg pain, and to test feasibility aspects.

Conditions

  • Chronic Low Back Pain
  • Chronic Sciatica
  • Lumbar Spinal Stenosis
  • Lumbar Disc Herniation
  • Lumbar Spondylolisthesis
  • Lumbago
  • Lumbar Disc Degeneration
  • Persistent Postoperative Pain

Interventions

OTHER

Zhineng Qigong intervention

The intervention consisted of group activities which were performed in one group, as lectures, demonstrations, and Zhineng Qigong training, all planned and led by European Zhineng Qigong. The group activities were performed during four weekends (12 hours each) and weekly training two times per week (each for two hours). Introductory lecture (two hours) was given at the evening before the first weekend. The respondents were recommended daily Zhineng Qigong training with help of an instructional training CD.

Sponsors & Collaborators

  • The Swedish Institute for Health Sciences

    collaborator UNKNOWN

  • Ekhaga foundation

    collaborator UNKNOWN

  • Greta and Johan Kock Foundation

    collaborator UNKNOWN

  • Lund University

    lead OTHER

Principal Investigators

  • Gabriella Pozarek, MD · Faculty of Medicine, Department of Health Sciences, Lund University, Sweden

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-06-30
Completion
2014-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04520334 on ClinicalTrials.gov